Miriam Kidron Net Worth & Insider Trades

Miriam Kidron - Chief Scientific Officer, Oramed Pharmaceuticals Inc

As of August 1, 2022

What is Miriam Kidron's Net Worth?

The current estimated net worth of Oramed Pharmaceuticals Inc's Chief Scientific Officer, Miriam Kidron, is estimated to be about $4.66M . Miriam Kidron owns about 75,000 units of Oramed Pharmaceuticals Inc common stock. In the last 15 years at Oramed Pharmaceuticals Inc, Miriam Kidron has sold an estimated value of $3.54M worth.

What is Miriam Kidron's Past Insider Trading?

Miriam Kidron's largest purchase order was 137,300 units , worth over $1.65K on April 3, 2014. Miriam Kidron's largest sale order was 137,300 units , worth over $1.65M on April 3, 2014. In total, Miriam Kidron has made about 22 transactions over 15 years of their time at Oramed Pharmaceuticals Inc. Miriam Kidron usually trades in August, February and September, with the busiest year in 2014. The most recent transaction was a sale order of 89,636 units , worth over $761.91K on August 3, 2017.

Miriam Kidron

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Miriam Kidron's Salary in 2020?

As Chief Scientific Officer of Oramed Pharmaceuticals Inc, Miriam Kidron has a total base salary of $305,840 . Miriam Kidron received compensation valued at about $688,700 in 2020 after becoming Chief Scientific Officer. The vast majority of their compensation came in the form of a bonus of $70,000 , option awards of $299,506 , and other compensation of $13,354 .

What is Miriam Kidron's' Mailing Address?

  • Mailing address is 2 Elza Street Jerusalem L3 93706 Israel

Oramed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Nadav Kidron 2020 $439,076 $220,582 $569,062 $539,131 $1,767,851
Nadav Kidron 2019 $419,460 $224,975 $398,910 $507,750 $1,551,095
Nadav Kidron 2018 $436,310 $148,795 $522,569 $442,326 $1,550,000
Miriam Kidron 2020 $305,840 $70,000 $299,506 $13,354 $688,700
Miriam Kidron 2019 $267,386 $123,149 $211,128 $14,503 $616,166
Miriam Kidron 2018 $273,595 $46,614 $253,204 $13,643 $587,056
Avraham Gabay 2020 $130,554 $15,591 - $44,912 $191,418
Avraham Gabay 2019 $32,122 - $73,928 $9,441 $115,491
Joshua Hexter 2020 $190,801 $12,169 $351,128 $54,735 $608,833
Joshua Hexter 2019 $52,848 - - $9,022 $61,870
Joshua Hexter 2018 $161,002 $26,895 $269,196 $50,505 $507,598
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm

What are Oramed Pharmaceuticals Inc's Past Insider Trades?

Oramed Pharmaceuticals Inc's most recent insider trade came on May 10, 2022 by Arie Mayer who sold 3,000 units worth $76.8K . In the last 13 years, insiders at Oramed Pharmaceuticals Inc have sold an estimated value of $12.41M and bought an estimated value of $6.19M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Miriam Kidron, Chief Scientific Officer,  Nadav Kidron, President and CEO,  and Leonard Sank, Director .

ORAMED PHARMACEUTICALS INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1